ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers.

Authors: Mitsiades, Irene Rin, Onozato, Maristela, Iafrate, A. John, Hicks, Daniel, Gülhan, Doğa C., Sgroi, Dennis C., Rheinbay, Esther

Source: Breast Cancer Research; 12/18/2024, Vol. 26 Issue 1, p1-15, 15p

Subject Terms: HER2 positive breast cancer, FLUORESCENCE in situ hybridization, GENE amplification, MEDICAL sciences, GENE expression